Delivery Order SPE2DB22D3009-SPE2DB24FAU92
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $3,003.51, has a completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,837.76 for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $28,218.97 and a completion date of May 30, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, involves the delivery of VIVITROL 380 MG VIAL-DILUENTS to support the U.S. government's medical and healthcare needs. The $12,599.09 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 30, 2024. The contract does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,017.52 and is a Firm Fixed Price Delivery Order that runs through August 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $12,666.36, has an ultimate completion date of December 30, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $18,286.20 firm fixed price delivery order has a period of performance through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.34, is for the delivery of Vivitrol 380 mg vials and diluents. The contract has an ultimate completion date of April 3, 2025 and is a firm fixed-price delivery order. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a specialized medication. The contract has a ceiling value of $12,014.04 and a period of performance through January 24, 2025. The contract is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery...
- This federal contract award for $14,211.69 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a specialty medication. The award is a Firm Fixed Price Delivery Order with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB24FAU92Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The award, valued at $15,106.44, was made on April 23, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 4/23/24 |